These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 30318009)

  • 1. Isolation, Purification, Characterisation and Application of L-ASNase: A Review.
    Paul T; Mondal A; Bandyopadhyay TK
    Recent Pat Biotechnol; 2019; 13(1):33-44. PubMed ID: 30318009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization and immobilization of Erwinia carotovoral-asparaginase in a microplate for high-throughput biosensing of l-asparagine.
    Labrou NE; Muharram MM
    Enzyme Microb Technol; 2016 Oct; 92():86-93. PubMed ID: 27542748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serum.
    Lanvers C; Vieira Pinheiro JP; Hempel G; Wuerthwein G; Boos J
    Anal Biochem; 2002 Oct; 309(1):117-26. PubMed ID: 12381370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of L-asparagine in CSF after intramuscular administration of asparaginase from Erwinia in children with acute lymphoblastic leukemia.
    Dibenedetto SP; Di Cataldo A; Ragusa R; Meli C; Lo Nigro L
    J Clin Oncol; 1995 Feb; 13(2):339-44. PubMed ID: 7844595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic l-asparaginase: upstream, downstream and beyond.
    Lopes AM; Oliveira-Nascimento L; Ribeiro A; Tairum CA; Breyer CA; Oliveira MA; Monteiro G; Souza-Motta CM; Magalhães PO; Avendaño JG; Cavaco-Paulo AM; Mazzola PG; Rangel-Yagui CO; Sette LD; Converti A; Pessoa A
    Crit Rev Biotechnol; 2017 Feb; 37(1):82-99. PubMed ID: 26694875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac: pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system.
    Albertsen BK; Schrøder H; Ingerslev J; Jakobsen P; Avramis VI; Müller HJ; Carlsen NT; Schmiegelow K
    Br J Haematol; 2001 Dec; 115(4):983-90. PubMed ID: 11843837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards development of biobetter: L-asparaginase a case study.
    Tripathy RK; Anakha J; Pande AH
    Biochim Biophys Acta Gen Subj; 2024 Jan; 1868(1):130499. PubMed ID: 37914146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells.
    Aslanian AM; Kilberg MS
    Biochem J; 2001 Aug; 358(Pt 1):59-67. PubMed ID: 11485552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia.
    Salzer WL; Asselin BL; Plourde PV; Corn T; Hunger SP
    Ann N Y Acad Sci; 2014 Nov; 1329():81-92. PubMed ID: 25098829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961).
    Panosyan EH; Grigoryan RS; Avramis IA; Seibel NL; Gaynon PS; Siegel SE; Fingert HJ; Avramis VI
    Anticancer Res; 2004; 24(2C):1121-5. PubMed ID: 15154634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding targets for a metabolic therapy of cancer: L-asparaginase.
    Covini D; Tardito S; Bussolati O; Chiarelli LR; Pasquetto MV; Digilio R; Valentini G; Scotti C
    Recent Pat Anticancer Drug Discov; 2012 Jan; 7(1):4-13. PubMed ID: 21854356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immobilization of L-asparaginase into a biocompatible poly(ethylene glycol)-albumin hydrogel: evaluation of performance in vivo.
    Jean-François J; D'Urso EM; Fortier G
    Biotechnol Appl Biochem; 1997 Dec; 26(3):203-12. PubMed ID: 9428158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme Engineering Strategies for the Bioenhancement of L-Asparaginase Used as a Biopharmaceutical.
    Miranda J; Lefin N; Beltran JF; Belén LH; Tsipa A; Farias JG; Zamorano M
    BioDrugs; 2023 Nov; 37(6):793-811. PubMed ID: 37698749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia.
    Hawkins DS; Park JR; Thomson BG; Felgenhauer JL; Holcenberg JS; Panosyan EH; Avramis VI
    Clin Cancer Res; 2004 Aug; 10(16):5335-41. PubMed ID: 15328169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment.
    Tsurusawa M; Chin M; Iwai A; Nomura K; Maeba H; Taga T; Higa T; Kuno T; Hori T; Muto A; Yamagata M;
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):204-8. PubMed ID: 14634792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia.
    Avramis VI; Tiwari PN
    Int J Nanomedicine; 2006; 1(3):241-54. PubMed ID: 17717965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial production, molecular modification, and practical application of l-Asparaginase: A review.
    Wang Y; Xu W; Wu H; Zhang W; Guang C; Mu W
    Int J Biol Macromol; 2021 Sep; 186():975-983. PubMed ID: 34293360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.
    Chan WK; Horvath TD; Tan L; Link T; Harutyunyan KG; Pontikos MA; Anishkin A; Du D; Martin LA; Yin E; Rempe SB; Sukharev S; Konopleva M; Weinstein JN; Lorenzi PL
    Mol Cancer Ther; 2019 Sep; 18(9):1587-1592. PubMed ID: 31209181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Strategies and Applications for l-Asparaginase Confinement.
    Nunes JCF; Cristóvão RO; Freire MG; Santos-Ebinuma VC; Faria JL; Silva CG; Tavares APM
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33321857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization and immunogenicity of silk fibroin-L-asparaginase bioconjugates.
    Zhang YQ; Zhou WL; Shen WD; Chen YH; Zha XM; Shirai K; Kiguchi K
    J Biotechnol; 2005 Nov; 120(3):315-26. PubMed ID: 16102867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.